Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000571146 | SCV000666267 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-08-16 | criteria provided, single submitter | clinical testing | The p.S105* pathogenic mutation (also known as c.314C>G), located in coding exon 3 of the BRIP1 gene, results from a C to G substitution at nucleotide position 314. This changes the amino acid from a serine to a stop codon within coding exon 3. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Myriad Genetics, |
RCV003335496 | SCV004045116 | pathogenic | Familial cancer of breast | 2023-05-30 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |